TDC
PRTA icon

Thompson Davis & Co’s Prothena Corp PRTA Stock Holding History

Thompson Davis & Co’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-125
Closed -$7K – 1186
2016
Q3 		$7K Hold
125
– – 0.01% 759
2016
Q2 		$4K Hold
125
– – 0.01% 833
2016
Q1 		$5K Buy
+125
New +$4.89K 0.01% 796

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Thompson Davis & Co's PRTA Position: Q4 2016 in Review

Thompson Davis & Co sold out of Prothena Corp (PRTA) in Q4 2016, closing a stake of 125 shares — an estimated $7K sold.

Thompson Davis & Co first reported a position in PRTA in Q1 2016 and held it in 3 quarters. The position peaked at $7K in Q3 2016. 145 funds tracked by Wall St. Rank hold PRTA as of Q4 2016.

  • Thompson Davis & Co reported no remaining Prothena Corp position as of Q4 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 125 Prothena Corp shares in Q4 2016, an estimated $7K.
  • Thompson Davis & Co first reported a position in Prothena Corp in Q1 2016 and held it in 3 quarters.
  • Thompson Davis & Co's Prothena Corp position peaked at $7K in Q3 2016.
  • 145 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2016.

Based on Thompson Davis & Co's 13F filing for Q4 2016, filed 7 Feb 2017.